ITI Treatment Guide Volume 14 - Home - ITI,Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development,Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumors | Journal for ImmunoTherapy of Cancer,Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8+ T cell responses: Immunity,ITI Treatment Guide Volume 13